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Abstract
Introduction: The normal circadian rhythm of hormones in critical patients becomes chaotic causing some hormones to increase and others 
to decrease abnormally. The goal of this study is to evaluate hormonal changes in severely ill patients and to investigate the relationship 
between hormonal changes and mortality and morbidity.
Material and methods: We enrolled 20 patients (10 F/10 M). Blood samples were collected on day 0, day 5, and day 10. If a patient was 
discharged before these defined days, a sample was drawn on that day. Twenty healthy controls were included.
Results: Female patients had lower LH, FSH, and fT3 and higher PRL and cortisol levels than controls on admission to the intensive care 
unit (ICU) (pLH = 0.021, pFSH:0.001, pfT3 = 0.021, pPRL = 0.042, pCortisol < 0.001, respectively). Men had significantly low testosterone and fT3, 
and high PRL and cortisol levels on ICU admission (pT = 0.01, pfT3 = 0.043, pPRL = 0.005, pCortisol < 0.001, respectively). The lowest levels of 
gonadotropins in both genders and testosterone in men were measured on day 5. Cortisol levels decreased in the patients discharged from 
the ICU (p = 0.01). FSH levels increased in recovered women (pFSH = 0.043). The mortality rate was 30%. There were correlations between 
admission TSH and NIMV duration (p = 0.006), fT3 and APACHE II (p = 0.001), and PRL and mortality (p = 0.044). Positive correlations 
between E2 and APACHE II (p = 0.003) in females, and PRL and APACHE II (p = 0.022) in males were also displayed.
Conclusions: Critically ill patients develop significant changes in neuroendocrine axes. Alterations in hormones correlate with the disease 
severity and mortality. (Endokrynol Pol 2016; 67 (3): 305–312)
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Streszczenie
Wstęp: Prawidłowy rytm dobowy wydzielania hormonów u chorych w stanie krytycznym staje się chaotyczny — wydzielanie jednych 
hormonów nadmiernie się zwiększa, natomiast innych maleje. Badanie przeprowadzono w celu oceny zmian stężeń hormonów u osób 
ciężko chorych oraz zbadanie zależności między zmianami stężeń hormonów a śmiertelnością I chorobowością.
Materiał i metody: Do badania włączono 20 chorych (10 K/10 M). Próbki krwi pobierano w dniach 0, 5 i 10. Jeśli pacjent został wypisany 
przed tymi dniami, próbkę pobierano w dniu wypisu. Utworzono również grupę kontrolną złożoną z 20 zdrowych osób.
Wyniki: U kobiet stwierdzono niższe stężenia LH, FSH i fT3 oraz wyższe stężenia PRL i kortyzolu przy przyjęciu na oddział intensywnej 
opieki medycznej (OIOM) niż u osób z grupy kontrolnej (odpowiednio pLH = 0,021; pFSH = 0,001; pfT3 = 0,021; pPRL = 0,042; pCortisol < 0,001). 
U mężczyzn w chwili przyjęcia na OIOM stężenia testosteron i fT3 były istotnie niższe, a stężenia PRL i kortyzolu wyższe niż w grupie 
kontrolnej (odpowiednio pT = 0,01; pfT3 = 0,043; pPRL = 0,005; pCortisol < 0,001). Najniższe stężenie gonadotropin u obu płci, a testosteron 
u mężczyzn zmierzono w dniu 5. Stężenia kortyzolu zmniejszyły się u chorych wypisanych z OIOM-u (p = 0,01). Stężenia FSH zwiększyły 
się u kobiet, których stan się poprawił (pFSH = 0,043). Odsetek zgonów wynosił 30%. Występowały korelacje między stężeniem TSH przy 
przyjęciu na OIOM a czasem stosowania nieinwazyjnej wentylacji mechanicznej (p = 0,006), fT3 i oceną w skali APACHE II (p = 0,001) 
oraz między stężeniem PRL a śmiertelnością (p = 0,044). Stwierdzono także dodatnie korelacje między stężeniem E2 a oceną w skali 
APACHE II (p = 0,003) u kobiet oraz między stężeniem PRL a ocean w skali APACHE II (p = 0,022) u mężczyzn.
Wnioski: U chorych w stanie krytycznym występują istotne zaburzenia osi neuroendokrynnych. Zmiany stężeń hormonów korelują 
z ciężkością choroby I śmiertelnością. (Endokrynol Pol 2016; 67 (3): 305–312)
Słowa kluczowe: śmiertelność; zmiany czynności neuroendokrynnej; prolaktyna; ciężka choroba
Introduction
Critical illness is associated with various neuroen-
docrine changes that have been linked to increased 
morbidity and mortality [1, 2]. Critical illness has two 
stages: acute (first few hours to days) and chronic stages 
(from seven days onwards). Each stage has unique 
neuroendocrine alterations. Cytokines are considered 
to be responsible for early changes, and increased 
endogenous dopamine, hypercortisolism, and medica-
tions ordered in the ICU are thought to be responsible 
for chronic alterations [1, 3]. 
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Testosterone (T) levels decrease during the early 
phase and the secretions of luteinising hormone (LH) 
and follicle stimulating hormone (FSH) are generally 
increased to attenuate T concentration [4, 5]. How-
ever, normal or low LH and FSH levels can sometimes 
be observed even though the simultaneous T level is 
low [5, 6]. In the chronic phase, T decreases further 
and gonadotropins are measured low, supporting 
hypothalamic-pituitary dysfunction [7, 8]. Similar 
alterations in LH and FSH values are encountered in 
women [4, 6, 9, 10].
Serum thyroid stimulating hormone (TSH) and free 
thyroxine (fT4) levels increase and free triiodothyronine 
(fT3) decreases shortly after an acute insult [11]. The low 
fT3 level is due to decreased peripheral conversion of fT4 
to fT3. The secretions of TSH and T4 increase to improve 
peripheral resistance [12]. After a few hours, TSH and 
fT4 levels return to normal [11]. In protracted patients, 
the fT3 concentration remains low, with low/normal 
TSH and fT4 levels [12, 13]. The prolactin (PRL) level 
increases during acute illness but decreases to a low/ 
/normal level in the chronic phase [13]. Hypothalamic-
pituitary dysfunction is also considered to be respon-
sible for alterations in thyroid and lactotrophic axes in 
protracted patients [3, 12, 13].
The aim of our study was first to determine serial 
changes in sex, thyroid, PRL, and cortisol hormones in 
severely ill patients. The second goal was to investigate 
the relationship between hormonal changes and mor-
bidity and mortality. 
Material and methods
Twenty critically ill patients (10 M/10 F) who were 
admitted to the ICU of Marmara University Hospital 
were included in the study. Admission diagnoses were 
pneumonia and heart failure (n: 4), gastrointestinal 
bleeding (n: 1), acute coronary syndrome (n: 1), diabetic 
ketoacidosis (n: 1), and sepsis due to pneumonia (n: 11), 
pyelonephritis (n: 2), and cholecystitis (n: 1). 
Exclusion criteria were age < 18 years; pre-existing 
neurological, psychiatric, metabolic, or endocrine dis-
eases (except diabetes mellitus); intracranial lesions, 
haemorrhage or infarction (except lacunar infarct); 
malignancy (except basal cell cancer); body mass index 
(BMI) < 18.5; renal failure requiring renal replacement 
therapy; chronic and acute liver disease; autoimmune 
diseases; HIV-positive patients; electrolyte distur-
bances; resuscitation; heavy alcohol intake (≥ 80 gr/ 
/day); premenopausal women; ICU admission for sim-
ple observation/monitoring; and concomitant treatment 
with calcium channel blockers, amiodarone, dopamine 
agonists/antagonists, benzodiazepines, opioids, im-
munosuppressants, antipsychotics, antidepressants, 
antiepileptics, thyroid hormones, oestrogens, and 
glucocorticoids. 
Severity of illness was rated by Acute Physiologic 
and Chronic Health Evaluation II scoring (APACHE 
II). Administration of drugs suspected of affecting the 
neuroendocrine axis and types of mechanical ventila-
tion [invasive and noninvasive MV (IMV and NIMV)] 
were recorded. Blood samples were collected within 
the first four hours of ICU admission and on days 
5 and 10. If a patient was discharged before these defined 
days, a sample was taken before leaving the ICU. After 
centrifugation, samples were kept frozen at –80oC until 
assayed. All patients were followed until they died or 
until they were discharged from the hospital. Twenty 
age- and BMI-matched healthy controls were included 
(Table I). Informed consent was obtained from the con-
trols and patients. The study protocol was approved by 
the ethics review board of Marmara University (MAR-
YC-2005-0092).
Assays
All samples from each patient were processed in the 
same run. LH, FSH, T, TSH, fT3, and fT4 were meas-
ured by the electrochemiluminescence immunoassay 
“ECLIA” method (Modular Analytics E170, Roche, 
America), PRL by the ECLIA method (Elecsys 2010, 
Roche, America), C-Reactive protein (CRP) by particle-
enhanced immunoturbidimetric assay (Hitachi 917, 
Roche, America), and estradiol (E2) and cortisol by 
chemiluminescent enzyme immunoassay (Immulite 
2000, Roche, America), as described elsewhere [6]. The 
intra-assay coefficient of variation for cortisol was 5.2% 
at 8.5 µg/dL and 6.2% at 26 µg/dL. 
Normal levels of LH, FSH, E2, and PRL for adult men 
are 1.7–8.6 mIU/mL, 1.42–15.4 mIU/mL, 0–30 pg/m, and 
4.04–15.2 ng/mL; for postmenopausal women 7.7–58.5 
mIU/mL, 19.3–100.6 mIU/mL, 0–56 pg/mL, and 4.79–23.3 
ng/mL, respectively. Normal levels of T for adult men 
are between 2.8 and 8.0 ng/mL. Normal limits of TSH, 
Table I. Demographics of the study groups 
Tabela I. Dane demograficzne badanej grupy
Sex Control* Patients* p
Female (n) 13 10
Age (year) 72.0 (63.0–83.5) 79.0 (67.5–81.7) 0.780
BMI [kg/m2] 27.4 (24.7–29.8) 26.3 (21.4–27.4) 0.186
Male (n) 7 10
Age (year) 74.0 (52.0–85.0) 74.0 (4.25–79.2) 0.758
BMI [kg/m2] 26.2 (20.3–27.5) 22.65 (22.2–27.3) 0.470
Total 20 20
*Values are expressed as median and interquartile ranges
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fT3, fT4, and cortisol are 0.27–4.2 µIU/mL, 2.6–4.4 pg/mL, 
0.93–1.7 ng/dL, and 10–22.4 µg/dL, respectively. 
Statistical analysis
Since data did not meet parametric test conditions, 
nonparametric tests were utilised. Study and control 
groups were compared using the Mann-Whitney U test 
for continuous variables. The Wilcoxon test was used to 
compare consecutive hormone values with one another. 
Correlations between variables were evaluated using 
the Spearman test. Results were expressed as median 
with interquartile ranges unless indicated otherwise. 
P < 0.05 was considered significant.
Results
The median APACHE II score was 25 (22–28) and 
admission CRP was 48.0 (30.2–52.8) mg/dL. Male and 
female patients had comparable APACHE II scores 
(p = 0.14) and CRP levels (p = 0.22). Energy intake was 
940 (940–1850) kcal/day. NIMV and IMV were applied to 
9 and 10 patients, respectively. The duration of NIMV 
was 46 (22–92) hours, IMV 75 (7–870) hours, ICU stay 
5 (2–10) days, and hospital stay 11 (3–26) days. Four 
patients (3M/1F) had tracheostomy. Multiorgan failures 
were recorded in 65% of patients and the mean number 
of affected organs was 4 ± 1.8.
Postmenopausal female patients had lower gonado-
tropins and fT3, and higher PRL, E2, and cortisol concen-
trations on admission to the ICU than control females 
(Table II). When women were reviewed individually, 
LH and FSH levels were low in seven patients and 
within normal limits in three patients. Abnormally low 
values for LH (≤ 5.0 mIU/mL) and FSH (≤ 10.0 mIU/mL) 
were measured in seven and five females, and severely 
depressed LH (≤1.0 mIU/mL) and FSH (≤ 5.0 mIU/mL) 
were measured in four and three women, respectively. 
Of the three patients with normal gonadotropins, two 
patients had normal LH and FSH levels during the ICU 
course and had non-infectious diagnoses (ketoacidosis 
and bleeding). The remaining patients had low gonado-
tropins during the ICU stay. 
The median levels of gonadotropins were noticed 
to decrease more on day 5, and the decrease in FSH 
concentrations became significant (Table II). Since there 
were just two patients on day 10, the median hormone 
levels were recorded: FSH: 5.3 (0.9–6.9) mlU/mL, LH: 
0.9 (0.3–1.1) mlU/mL, E2: 76.4 (38.1–76.5) pg/mL, PRL: 
58.0 (9.1–77.9) ng/mL, cortisol: 18.2 (10.9–16.4) µg/dL, 
TSH: 1.7(1.0–1.6) µlU/mL, fT3: 1.2 (0.9–0.9) pg/m L, and 
fT4: 1.07 (0.55–1.06) ng/mL. When hormones of seven 
discharged patients were compared with their admis-
sion values, a small but significant rise only in the FSH 
concentration was observed [FSHadmission:6.9 (4.4–60.1) 
vs. FSHdischarge: 7.3 (1.5–59.8) mlU/mL, p = 0.043].
Male patients had low T and fT3, and high PRL and 
cortisol levels (Table III) on admission. T concentrations 
were below the normal limits in 80% of the subjects. Of 
the patients with low T, four patients had hypergon-
adotrophic hypogonadism (high LH and high/normal 
FSH), and the other half had hypogonadotrophic hypo-
gonadism (normal/Low LH and FSH). Gonadotropins 
and T were reduced further on day 5, and the reduction 
of T and FSH reached statistical significance. All patients 
had low T levels during the ICU course. LH and FSH 
levels tended to increase on day 10 but did not reach 
statistical significance. Since blood samples of three men 
were studied on discharge, the statistics could not be 
Table II. Hormone levels of female patients
Tabela II. Stężenia hormonów u kobiet
Parameters Controls  
(n:13)
Female patients 
Day 0 (n:10)
p† Female patients 
Day 5 (n:8)
p‡
LH [mlU/mL] 26.5 (20.6–33.1) 3.1 (0.4–30.2) 0.021 1.9 (0.4–25.8) 0.401
FSH [mlU/mL] 70.2 (62.3–88.1) 9.9 (3.8–60.0) 0.001 6.1 (1.7–49.9) 0.025
E2 [pg/mL] 27.0 (20.2–31.0) 65.8 (36.1–124.2)  < 0.001 42.2 (27.6–102.5) 0.327
PRL [ng/mL] 12.4 (9.1–19.9) 22.1 (11.1–39.0) 0.042 20.1 (11.8–38.3) 0.329
Cortisol [μg/dL] 16.4 (14.3–20.9) 27.3 (22.2–41.7)  < 0.001 16.5 (13.9–32.5) 0.050
TSH [μlU/mL] 1.8 (1.2–2.9) 1.9 (0.3–4.8) 0.784 1.8 (0.2–3.6) 0.779
fT3 [pg/mL] 2.8 (2.5–3.2) 1.9 (1.7–3.1) 0.021 1.6 (1.2–2.3) 0.575
fT4 [ng/mL] 1.2 (1.1–1.3) 1.3 (0.9–1.9) 0.410 1.2 (0.9–1.6) 0.889
APACHE II 23 (20–26) 15 (11–12) 0.012
CRP [mg/dL] 0.78 (0.78–0.78) 46.1 (18.4–52.2)  0.001 29.1 (10.3–48.9) 0.735
†Hormone levels of the patients on ICU admission were compared with the hormone levels of healthy controls. ‡represents the comparison between the hormone levels 
measured on days 0 and 5 in eight patients. Values are expressed as median and interquartile ranges; p < 0.05 denotes significant differences between groups
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applied and the median hormone levels were noted: 
FSH: 4.2 (2.3–6.5) mlU/mL, LH: 12.6 (8.4–12.9) mlU/mL, 
E2: 57.3 (43.3–216.0) pg/mL, PRL: 17.5 (6.7–26.4) ng/mL, 
T: 0.8 (0.6–0.9) ng/mL, TSH: 2.8 (0.3–3.79) µlU/mL, fT3: 
2.0 (1.4–2.3) pg/mL, and fT4: 0.97 (0.90–1.46) ng/mL.
Medications given to the patients during the ICU 
stay included methylprednisolone (5 M), neuroleptic 
(3 M/3 F), dopamin (2 M), benzodiazepine (1 M), 
and morphine (1 F). A statistical evaluation could not be 
done for medications due to the small numbers. Meth-
ylprednisolone was given to vasopressor unresponsive 
septic shock patients. Four men under methylpredniso-
lone therapy had TSH levels between 0.089–0.007 µlU/ 
/mL on days 5 and 10. They had normal TSH values on 
admission to the ICU. 
When thyroid hormones and PRL of all 20 patients 
were compared with the hormones of healthy subjects, 
fT3 was found to be significantly low, and PRL and corti-
sol were seen to be high (Table IV). Except for cortisol, no 
significant changes in thyroid hormone and PRL levels 
were documented compared to the admission values in 
10 discharged patients, and none of these patients was on 
methylprednisolone therapy. Four patients had hormone 
levels measured on day 15 (3 M/1 F). The sex hormonal 
profiles of these three patients with different clinical 
courses were individually depicted in graphics (Fig. 1–3).
Table III. Hormone levels of male patients
Tabela III. Stężenia hormonów u mężczyzn
Parameters Controls (n:7) Male patients 
Day 0 (n:10)
p† Male patients 
Day 5 (n:6)
p‡ Male patients 
Day 10 (n:5)
pt
LH [mlU/mL] 5.2 (4.4–8.7) 9.4 (5.3–12.7) 0.368 4.7 (1.4–9.2) 0.463 8.9 (4.8–11.1) 0.080
FSH [mlU/mL] 4.9 (4.2–22.3) 3.5 (2.4–7.0) 0.220 2.1 (0.8–3.9) 0.028 3.5 (1.5–5.9) 0.080
E2 [pg/mL] 36.4 (27.3–47.7) 54.8 (28.6–121.6) 0.492 54.0 (34.2–91.8) 0.345 43.1 (33.8–129.6) 0.686
T [ng/mL ] 3.4 (2.3–5.3) 1.3 (0.9–2.4) 0.010 0.4 (0.2–0.8) 0.046 0.6 (0.2–0.8) 0.500
PRL [ng/mL] 9.7 (7.5–11.6) 21.2 (12.7–47.1) 0.005 18.4 (12.4–24.2) 0.116 24.0 (4.5–29.5) 0.686
Cortisol [μg/dL] 12.6 (10.1–14.1) 32.5 (29.0–41.3)  < 0.001 12.7 (9.6–37.6)§ 0.109 18.4 (6.0–19.1)§ 0.593
TSH [μlU/mL] 1.1 (0.9–1.5) 0.9 (0.4–2.0) 0.713 0.5 (0.06–2.3)¶ 0.249 0.06 (0.03–2.0)¶ 0.893
fT3 [pg/mL] 3.1 (2.6–3.8) 2.3 (1.2–2.9) 0.043 2.1 (1.7–3.2) 0.917 1.8 (1.6–3.1) 0.345
fT4 [ng/mL] 1.2 (1.1–1.3) 1.1 (0.9–1.5) 0.475 1.3 (0.9–1.5) 0.600 1.2 (1.0–1.4) 0.893
APACHE II – 25 (24–32)  20 (13–28) 0.042 19 (9–30)  1.000
CRP [mg/dL] 2.7 (0.78–4.5) 48.0 (43.7–72.2)  0.006 34.7 (26.3–44.2) 0 0.173 38.2 (6.2–42.5)  0.345
†Hormone levels of the patients on ICU admission were compared with the hormone levels of healthy controls. ‡represents the comparison between the hormone levels 
measured on days 0 and 5 among six patients. tindicates the statistical differences between hormone levels measured on days 5 and 10 in five patients. ¶Five patients 
had methylprednisolone therapy on days 5 and 10. Four males among these patients had low TSH levels on days 5 and 10, ranging between 0.089 and 0.007 μlU/mL. 
These patients had normal TSH values on ICU admission. §Cortisol levels measured on days 5 and 10 in five patients were under methylprednisolone therapy. Values are 
expressed as median and interquartile ranges; p < 0.05 denotes significant differences between groups.
Table IV. Thyroid hormone, cortisol, and PRL levels on admission to and prior to discharge from the ICU
Tabela IV. Stężenia hormonów tarczycy, kortyzolu i PRL przy przyjęciu na OIOM i przed wypisaniem z OIOM-u
Parameters* Controls (n:20) Patients (n:20) p† Discharge (n:10) p‡
TSH [μlU/mL] 1.4 (1.1–2.6) 1.07 (0.4–3.1) 0.355 1.9 (0.6–3.8) 0.722
fT3 [pg/mL] 2.9 (2.6–3.3) 2.1 (1. 7–2.6) 0.001 1.8 (1.3–2.3) 0.657
fT4 [ng/mL] 1.2 (1.1–1.3) 1.3 (0.9–1.7) 0.904 1.2 (1.1–1.4) 0.722
PRL [ng/mL] 11.4 (8.9–12.8) 21.3 (12.56–39.9) 0.004 17.5 (11.4–34.9) 0.790
Cortisol [μg/dL] 16.1 (12.1–20.1) 30.8 (25.4–39.4)  < 0.001 17.4 (1.4–21.7) 0.010
APACHE II 25 (22–28) 12 (7–16) 0.005
CRP 0.78 (0.78–2.6) 48.0 (30.2–52.8) < 0.001 24.5 (9.5–41.0) 0.074
*None of the patients had methylprednisolone therapy. †The hormone levels of the patients on ICU admission were compared with the hormone levels of healthy 
controls. ‡denotes the statistical comparison between hormone levels measured on admission to and discharge from the ICU among 10 patients. Values are expressed 
as median and interquartile ranges; p < 0.05 denotes significant differences between groups
309
Endokrynologia Polska 2016; 67 (3)
PR
A
C
E 
O
RY
G
IN
A
LN
E
Figure 1. An 83-year-old male patient was admitted to the ICU with severe pneumonia and acute coronary syndrome. The hormone 
levels increased as the patient got better
Rycina 1. Chory w wieku 83 lat został przyjęty na OIOM z ciężkim zapaleniem płuc i ostrym zespołem wieńcowym. Kiedy stan chorego 
się poprawił, stężenia hormonów wzrosły
Figure 2. A 50-year-old male patient was admitted with pneumonia and severe ARDS. As the patient got better, hormone levels increased. 
Then, the patient had severe sepsis due to ventilator-associated pneumonia and hormone levels started to fall again
Rycina 2. Chory w wieku 50 lat został przyjęty na OIOM z powodu zapalenia płuc i ciężkiego zespołu niewydolności oddechowej. Kiedy 
stan pacjenta się poprawił, nastąpiło zwiększenie stężeń hormonów. Następnie u chorego rozwinęła się ciężka posocznica spowodowana 
respiratorowym zapaleniem płuc i stężenia hormonów znów uległy obniżeniu
Figure 3. An 80-year-old female patient was admitted with cholecystitis-related severe sepsis and developed multiorgan failure. The 
patient could not be weaned from MV and stayed in the ICU for more than one month. Hormone levels stayed low during the ICU 
course. The patient was sent to a nursing home with a home ventilator
Rycina 3. Chora w wieku 80 lat została przyjęta na OIOM z powodu ciężkiej posocznicy związanej z zapaleniem pęcherzyka żółciowego. 
Rozwinęła się niewydolność wielonarządowa. Pacjentka wymagała wentylacji mechanicznej i pozostała na OIOM-ie przez ponad miesiąc. 
W czasie pobytu na OIOM-ie stężenia hormonów pozostawały niskie. Chora została odesłana do placówki opiekuńczej z zaleceniem 
stosowania respiratora do użytku w warunkach domowych
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There were significant correlations between admis-
sion TSH and NIMV duration (r: 0.83, p = 0.006), fT3 and 
APACHE II (r: 0.69, p = 0.001), and PRL and mortality 
(r: 0.45, p = 0.044) in 20 patients. Significant correlations 
between these variables were also illustrated when 
both genders were analysed separately. Positive cor-
relations between E2 and APACHE II (r: 0.83, p = 0.003) 
in females, and PRL and APACHE II (r: 0.71, p = 0.022) 
in males were displayed. The association between 
mortality and T (r = –0.61, p = 0.063) in males, and 
mortality and E2 (r = 0.62, p = 0.054) in females was high 
but did not reach statistical significance. Six patients 
(6 M/2 F) died due to sepsis (n: 6) and cardiac reasons 
(n: 2). None died after ICU discharge. Admission hor-
monal values of deceased men were not different from 
surviving ones. The hormonal comparisons between 
deceased and surviving female patients could not be 
done due to limited numbers.
Discussion
In the current study, the male subjects had lower T con-
centrations than controls. T levels continued to decline 
further during the first week of critical illness, which 
is in line with the literature [4, 5, 14]. T concentration 
decreases in many systemic diseases and critical illness 
[4, 14, 15]. As the disease becomes serious, the decline 
becomes more severe [14, 16]. The reason for decreased 
T is the inhibition of testicular androgenesis or central 
LHRH secretion or both. Cytokines have been shown 
to take part in either situation [17, 18]. Our patients had 
high CRP concentrations and APACHE II scores that 
prove the presence of inflammation and disease sever-
ity. We observed a high correlation between mortality 
and admission T values, but it did not reach statistical 
significance, probably due to the small study group.
As demonstrated in our patients, LH and FSH 
levels decrease in severely ill women [4, 6, 9, 14]. The 
decrease was not dependent on disease type, patient’s 
age, and medications used [5, 14]. A decline in gon-
adotropins occurred within 24 hours of an acute insult 
and continued until the nadir decline in 4-6 days, as in 
the present study [4, 14]. As the disease becomes more 
severe, so the hormonal suppression gets worse, with 
very low LH (£ 0.5 mlU/mL) and FSH (£ 1 mlU/mL) 
[9, 14]. We observed severely depressed values with LH 
£ 1.0 mIU/mL in four and FSH ≤ 5.0 mIU/mL in three 
women on admission, and even lower LH (£ 0.5 mlU/ 
/mL) and FSH (≤ 1 mlU/mL) levels in three and one 
patient/s, respectively, during ICU stay. The presence 
of inflammation is considered to be responsible for 
hormonal alterations [19]. Our patients had high AP-
PACHE II scores and CRP levels that exhibited disease 
severity and presence of inflammation, except for two 
females who had non-infectious diagnosis and normal 
gonadotropins. 
Suppressed hormones rebound with disease im-
provement [9, 10, 20]. In our patients, discharged female 
patients had a significant increase in FSH levels. Since 
LH is more severely affected than FSH, the rise in FSH 
occurs first during recovery [6, 20]. Return of gonadotro-
pins to normal limits was reported to take months, even 
years in some patients [6, 9, 10]. Since we did not have 
serial hormone measurements after ICU discharge, we 
could not say anything about the return of gonadotro-
pins to normal limits. However, even small increases 
in FSH levels proved that the synthesis and secretion 
of hormones were enhanced in clinically improved 
patients. The same is true for T, and the normalisation 
of T was reported to take 2–12 months [4–6]. Our three 
male patients had low T levels when discharged from 
the ICU, in accordance with the literature. 
In this study, the median fT3 level was detected to 
be low and the result is similar to other studies that 
included seriously ill patients [2, 6, 21]. Severe physical 
stress, such as surgery, starvation, trauma, and infection, 
leads to alterations in the thyroid axis within hours [1, 
11, 21]. The drop in fT3 correlates with disease severity 
[2, 21]. We could not show this relation, probably due to 
inclusion of a small group of patients. We showed high E2 
levels in female patients and a correlation between E2 and 
disease severity. E2 level increases in critically ill patients 
[22, 23] and is reported to be associated with mortality 
[24]. Elevated aromatisation of adrenal androgens to E2 
mediated by cytokines is proven to result in increased 
serum E2 levels [23, 25]. PRL also increases in response 
to acute illness [6, 22, 26]. We showed that male and fe-
male critically ill patients had high PRL levels compared 
to controls, and correlations between admission PRL 
and mortality and disease severity were observed that 
were new findings compared to the literature. Highly 
elevated PRL can show disease severity, as our patients 
had elevated CRP levels and APACHE II scores. 
There are some limitations of this study. First, we 
studied a small number of patients. This could be an 
important reason for not demonstrating relationships 
between hormonal changes and mortality and morbid-
ity, except for PRL, TSH, and E2. Second, we did not 
make serial hormonal measurements after the patients 
left the hospital. Therefore, we can say nothing about 
the course of hormones. Third, we just included medical 
patients. The result could not be generalised to other 
groups of patients.
Conclusions
We have shown significant changes in the neuroendo-
crine system of seriously ill patients. Female patients 
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had low gonadotropins and fT3, but high PRL, E2, and 
cortisol levels, while males had low T and high PRL 
and cortisol levels on the day of ICU admission. The 
concentrations of gonadotropins in females and T in 
males decreased further during ICU stay. Since the pa-
tients had severe disease with regard to high APACHE 
II scores and CRP levels, they presented with severe 
hormonal changes. 
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